{"id":"https://openalex.org/W3096955010","doi":"https://doi.org/10.1182/blood-2020-141464","title":"XPO1 Relieves MYC-Induced Replication Stress Limiting the Immunogenicity of DLBCL Cells","display_name":"XPO1 Relieves MYC-Induced Replication Stress Limiting the Immunogenicity of DLBCL Cells","publication_year":2020,"publication_date":"2020-11-04","ids":{"openalex":"https://openalex.org/W3096955010","doi":"https://doi.org/10.1182/blood-2020-141464","mag":"3096955010"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-141464","doi":"https://doi.org/10.1182/blood-2020-141464","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-141464","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024621145","display_name":"Rossella Marullo","orcid":"https://orcid.org/0000-0002-1803-2700","observed_orcids":["https://orcid.org/0000-0002-1803-2700"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rossella Marullo","raw_affiliation_strings":["Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069617676","display_name":"Maria Victoria Revuelta","orcid":"https://orcid.org/0000-0002-7922-0713","observed_orcids":["https://orcid.org/0000-0002-7922-0713"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Victoria Revuelta","raw_affiliation_strings":["Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085952286","display_name":"Nahuel Zamponi","orcid":"https://orcid.org/0000-0002-9596-1095","observed_orcids":["https://orcid.org/0000-0002-9596-1095"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nahuel Zamponi","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090324252","display_name":"Sarah C. Rutherford","orcid":"https://orcid.org/0000-0002-1064-7727","observed_orcids":["https://orcid.org/0000-0002-1064-7727"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah C. Rutherford","raw_affiliation_strings":["Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040141808","display_name":"Peter Martin","orcid":"https://orcid.org/0000-0001-7813-1551","observed_orcids":["https://orcid.org/0000-0001-7813-1551"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Martin","raw_affiliation_strings":["Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY","institution_ids":["https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006640724","display_name":"Giorgio Inghirami","orcid":"https://orcid.org/0000-0001-5566-0864","observed_orcids":["https://orcid.org/0000-0001-5566-0864","https://orcid.org/0000-0002-5298-6516"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giorgio Inghirami","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037882455","display_name":"John Paul Leonard","orcid":"https://orcid.org/0000-0002-5083-1115","observed_orcids":["https://orcid.org/0000-0002-5083-1115"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John P. Leonard","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059389744","display_name":"Leandro C. A. Cerchietti","orcid":"https://orcid.org/0000-0003-0608-1350","observed_orcids":["https://orcid.org/0000-0003-0608-1350"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leandro Cerchietti","raw_affiliation_strings":["Weill Cornell Medical College, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medical College, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"136","issue":"Supplement 1","first_page":"18","last_page":"18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11841","display_name":"Nuclear Structure and Function","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11841","display_name":"Nuclear Structure and Function","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.04320000112056732,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.02449999935925007,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/xpo1","display_name":"CRM1","score":0.9919999837875366},{"id":"https://openalex.org/keywords/selinexor","display_name":"selinexor","score":0.9769999980926514},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.906000018119812},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.890999972820282},{"id":"https://openalex.org/keywords/replication-stress","display_name":"replication stress","score":0.9879999756813049},{"id":"https://openalex.org/keywords/dna-damage-tolerance","display_name":"DNA damage tolerance","score":0.6230000257492065},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.8309999704360962},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.8379999995231628},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.8270000219345093},{"id":"https://openalex.org/keywords/wee1","display_name":"WEE1","score":0.7260000109672546},{"id":"https://openalex.org/keywords/myc-translocation","display_name":"MYC translocation","score":0.8140000104904175},{"id":"https://openalex.org/keywords/double-hit-lymphoma","display_name":"double-hit lymphoma","score":0.9229999780654907},{"id":"https://openalex.org/keywords/chromosomal-instability","display_name":"chromosomal instability","score":0.9890000224113464},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7680000066757202},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.35499998927116394},{"id":"https://openalex.org/keywords/xpo1-inhibitor","display_name":"XPO1 inhibitor","score":0.49300000071525574}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6603920459747314},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.6327908635139465},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5819653868675232},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5351150035858154},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.5226083397865295},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.5189476013183594},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5102150440216064},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3674526810646057},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.26243942975997925},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1788097620010376},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13461294770240784}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-141464","doi":"https://doi.org/10.1182/blood-2020-141464","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-141464","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387397274","https://openalex.org/W2562798146","https://openalex.org/W3169767623","https://openalex.org/W6901827329","https://openalex.org/W3095175318","https://openalex.org/W2253821251","https://openalex.org/W4417016977","https://openalex.org/W2980207618","https://openalex.org/W7212949060","https://openalex.org/W4388014138"],"abstract_inverted_index":{"The":[0,392],"soluble":[1],"nuclear":[2,27,102],"pore":[3,103],"component":[4],"XPO1":[5,23,39,67,83,97,125,251,365,513,588,620],"is":[6,84,127,486],"a":[7,30,325,332,530,583],"therapeutic":[8,78,616],"target":[9],"in":[10,20,69,88,168,203,315,322,458,535,576,589,622],"DLBCL":[11,154,330,435,481,518,557,591,608],"and":[12,74,86,225,248,253,265,313,404,483,514,560,564,609],"its":[13],"selective":[14],"inhibitor":[15],"selinexor":[16,52,149,177,300,308,336,385,475,534,562,567],"received":[17],"FDA":[18],"approval":[19],"relapsed/refractory":[21],"DLBCL.":[22,89],"inhibitors":[24,68,621],"block":[25],"the":[26,36,45,48,63,91,101,106,130,214,235,297,361,369,374,441,462,477,536,569],"export":[28],"of":[29,32,38,51,59,66,71,76,108,133,200,216,238,246,268,282,299,307,318,335,364,371,379,394,440,451,479,512,533,538,549,572],"subset":[31],"cargo":[33],"proteins.":[34],"Since":[35,410],"spectrum":[37],"cargos":[40],"varies":[41],"among":[42],"cell":[43,182,310,319],"types,":[44],"mechanism":[46],"underlying":[47],"anti-lymphoma":[49,131],"effect":[50,132,228,298,485,532],"has":[53],"not":[54],"been":[55],"fully":[56],"elucidated.":[57],"Lack":[58],"this":[60,124,227,239,293,398,430,484],"knowledge":[61],"hampers":[62],"clinical":[64,236],"use":[65],"terms":[70],"patient":[72],"selection":[73],"development":[75],"rational":[77],"combinations.":[79],"We":[80],"reported":[81],"that":[82,96,148,174,250,276,384,421,474,499,566,604],"amplified":[85],"overexpressed":[87],"At":[90],"molecular":[92],"level,":[93],"we":[94,121,146,172,241,295,367,419,432,497,542,629],"described":[95],"overexpression":[98,254],"functionally":[99],"remodels":[100],"to":[104,117,160,176,352,437,461,465,517,593],"sustain":[105],"expression":[107,137,187,215],"DNA":[109,139,201,412,442],"damage":[110,140,202,413],"repair":[111,220],"proteins":[112,221],"increasing":[113],"lymphoma":[114,262],"cells'":[115],"tolerance":[116],"genotoxic":[118],"stress.":[119,163,491],"Here,":[120],"investigated":[122,321],"whether":[123],"role":[126,586],"relevant":[128],"for":[129,470,525,587],"selinexor.":[134,232],"Aberrant":[135],"MYC":[136,151,167,186,212,258,515],"induces":[138],"resulting":[141],"from":[142,373,397,555,615],"replication":[143,162,218,490,596],"stress;":[144],"thus,":[145],"speculated":[147],"kills":[150],"expressing":[152,166],"(MYC+)":[153],"cells":[155,436,459,482,545,553,575,592],"by":[156,207,231,356,408,488,493,504],"limiting":[157,599],"their":[158,448,600],"ability":[159],"tolerate":[161,594],"Using":[164],"B-cells":[165],"an":[169,415,505,520,627],"inducible":[170],"manner,":[171],"demonstrated":[173],"exposure":[175],"(6":[178],"h)":[179],"caused":[180],"G2-M":[181],"cycle":[183,193,311],"arrest":[184,194,312],"upon":[185],"(p<0.0001,":[188],"vs.":[189,342],"vehicle-treated":[190],"cells).":[191],"Cell":[192],"was":[195,229,255,350,406,455],"associated":[196,256],"with":[197,257,519,606,624],"increased":[198,213],"levels":[199,267,281,511],"S-phase":[204],"as":[205,354],"measured":[206],"yH2AX":[208],"(p<0.0001).":[209],"Furthermore,":[210,492],"although":[211],"key":[217,395,584],"stress":[219,597],"(i.e.":[222,400],"RAD51,":[223],"WEE":[224],"BRCA1),":[226],"blunted":[230],"To":[233,290,359,428,528],"determine":[234,529],"relevance":[237],"mechanism,":[240,294],"interrogated":[242],"publicly":[243],"available":[244],"datasets":[245],"DLBCLs":[247,496],"found":[249,498,565],"amplification":[252],"translocation":[259],"(p<0.005),":[260,264],"double-hit":[261],"signature":[263],"elevated":[266,610],"chromosomal":[269],"instability":[270,284,612],"(p<0.005).":[271],"Overall,":[272,579],"these":[273,422],"observations":[274],"suggest":[275,603],"MYC-driven":[277],"lymphomas":[278],"sustaining":[279],"high":[280],"genomic":[283,611],"may":[285,613],"critically":[286],"depend":[287],"on":[288,301,619],"XPO1.":[289],"therapeutically":[291],"capitalized":[292],"evaluated":[296],"MYC+":[302,329,434,480,607],"DLBCLs.":[303],"Clinically":[304],"achievable":[305],"doses":[306,439],"induced":[309,386],"apoptosis":[314,353],"83%":[316],"(5/6)":[317],"lines":[320],"vitro.":[323],"In":[324],"patient-derived":[326],"xenograft":[327],"(PDX)":[328],"model,":[331],"human-equivalent":[333],"dose":[334],"impaired":[337],"tumor":[338,348],"growth":[339,349],"(p<":[340],"0.05,":[341],"vehicle)":[343],"without":[344],"significant":[345],"toxicities.":[346],"Reduced":[347],"secondary":[351],"determined":[355],"TUNEL":[357],"(p<0.05).":[358],"characterize":[360],"biological":[362],"effects":[363,423],"inhibition,":[366],"compared":[368,464,516],"transcriptome":[370],"PDX":[372],"previous":[375],"experiment.":[376],"Pathway":[377],"analysis":[378,547],"differentially":[380],"expressed":[381,509],"genes":[382,396,454],"revealed":[383],"pathways":[387],"regulating":[388],"innate":[389,416,452],"immune":[390,417,453,506,521,539],"signaling.":[391],"upregulation":[393],"pathway":[399],"DDX58,":[401],"DDX60,":[402],"IRF7":[403],"STAT1)":[405],"validated":[407],"qRT-PCR.":[409],"unrepaired":[411],"elicits":[414],"response,":[418],"hypothesized":[420],"could":[424],"be":[425],"mechanistically":[426],"linked.":[427],"test":[429,631],"notion,":[431],"exposed":[433,460],"sub-lethal":[438],"damaging":[443],"agent":[444],"etoposide,":[445],"selinexor,":[446],"or":[447],"combination.":[449],"Expression":[450],"significantly":[456],"higher":[457,510],"combination":[463,623],"either":[466],"drug":[467],"alone":[468],"(p<0.001,":[469],"both":[471,526,577],"comparisons),":[472],"indicating":[473],"increases":[476,568],"immunogenicity":[478],"enhanced":[487],"concomitant":[489],"analyzing":[494],"primary":[495],"poorly":[500],"immunogenic":[501],"lymphomas,":[502],"characterized":[503],"deserted":[507],"microenvironment,":[508],"rich":[522],"microenvironment":[523],"(P<0.001,":[524],"genes).":[527],"potential":[531],"function":[537],"effector":[540],"cells,":[541],"performed":[543],"single":[544],"secretomic":[546],"(Isolight)":[548],"circulating":[550],"CD8+":[551,573],"T":[552,574],"obtained":[554],"two":[556],"patients":[558,605],"before":[559],"after":[561],"treatment":[563],"secretory":[570],"activity":[571],"patients.":[578],"our":[580],"study":[581],"reveals":[582],"oncogenic":[585],"enabling":[590],"MYC-induced":[595],"while":[598],"immunogenicity.":[601],"This":[602],"benefit":[614],"approaches":[617],"based":[618],"immunomodulatory":[625],"drugs,":[626],"approach":[628],"will":[630],"prospectively.":[632],"Disclosures":[633],"Rutherford:":[634],"AstraZeneca:":[635,718],"Consultancy;":[636,638,640,645,647,653,665,667,669,675,677,679,681,683,685,687,689,693,695,697,699,701,704,707,709,711,713,715,717],"Celgene:":[637,676],"Dova:":[639],"Genentech/Roche:":[641],"Research":[642,650,656,659,672,721,726],"Funding;":[643,651,657,660,673,722],"Heron:":[644],"Juno:":[646],"Karyopharm:":[648,670,712],"Consultancy,":[649,671],"Kite:":[652,688],"LAM":[654],"Therapeutics:":[655,703],"Regeneron:":[658,700],"Seattle":[661],"Genetics:":[662],"Consultancy.":[663,691,719],"Martin:Regeneron:":[664],"Cellectar:":[666],"Janssen:":[668],"Teneobio:":[674],"Bayer:":[678,708],"Beigene:":[680],"Sandoz:":[682],"I-MAB:":[684],"Morphosys:":[686],"Incyte:":[690],"Leonard:Miltenyi:":[692],"Sutro:":[694],"Roche/Genentech:":[696],"BMS/Celgene:":[698],"ADC":[702],"MEI":[705],"Pharma:":[706],"Gilead/Kite:":[710],"GenMab:":[714],"Epizyme:":[716],"Cerchietti:Cellgene:":[720],"Bristol":[723],"Myers":[724],"Squibb:":[725],"Funding.":[727]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2020-11-09T00:00:00"}